+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

Recombinant Proteins Market Report 2023-2033 - Product Thumbnail Image

Recombinant Proteins Market Report 2023-2033

  • Report
  • April 2023
  • 353 Pages
  • Global
From
Therapeutic Proteins Global Market Report 2024 - Product Thumbnail Image

Therapeutic Proteins Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Recombinant Proteins Global Market Report 2024 - Product Thumbnail Image

Recombinant Proteins Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • March 2024
  • 181 Pages
  • Global
From
From
From
From
Global Recombinant Proteins Market 2023-2027 - Product Thumbnail Image

Global Recombinant Proteins Market 2023-2027

  • Report
  • April 2023
  • 167 Pages
  • Global
From
Global Protein Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Protein Therapeutics Market 2023-2027

  • Report
  • March 2023
  • 180 Pages
  • Global
From
From
From
From
Global Biopharmaceuticals Market Outlook to 2027 - Product Thumbnail Image

Global Biopharmaceuticals Market Outlook to 2027

  • Report
  • July 2023
  • 80 Pages
  • Global
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more